A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.

Saved in:
Bibliographic Details
Title: A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
Authors: Vize CJ; Department of Ophthalmology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Kim SK; Department of Ophthalmology and Visual Science, University of Texas McGovern Medical School, Houston, Texas, USA., Matthews T; Birmingham Neuro-Ophthalmology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Macsai M; Northshore University Health System, Glenview, Illinois, USA., Merrell R; NorthShore University Health System, Evanston, Illinois, USA., Hsu S; The Vivian L. Smith Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA., Kundu MG; AbbVie, North Chicago, Illinois, USA., Yoon J; AbbVie, North Chicago, Illinois, USA., Kennedy E; AbbVie, North Chicago, Illinois, USA., Pai M; AbbVie, North Chicago, Illinois, USA., Bain E; AbbVie, North Chicago, Illinois, USA., Lassman AB; Division of Neuro-Oncology, Department of Neurology and the Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York, USA., Moazami G; Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
Source: Ophthalmic research [Ophthalmic Res] 2023; Vol. 66 (1), pp. 1030-1043. Date of Electronic Publication: 2023 May 31.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0267442 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0259 (Electronic) Linking ISSN: 00303747 NLM ISO Abbreviation: Ophthalmic Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37257422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vize+CJ%22">Vize CJ</searchLink>; Department of Ophthalmology, Hull University Teaching Hospitals NHS Trust, Hull, UK.<br /><searchLink fieldCode="AU" term="%22Kim+SK%22">Kim SK</searchLink>; Department of Ophthalmology and Visual Science, University of Texas McGovern Medical School, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Matthews+T%22">Matthews T</searchLink>; Birmingham Neuro-Ophthalmology Unit, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Macsai+M%22">Macsai M</searchLink>; Northshore University Health System, Glenview, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Merrell+R%22">Merrell R</searchLink>; NorthShore University Health System, Evanston, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+S%22">Hsu S</searchLink>; The Vivian L. Smith Department of Neurosurgery, University of Texas McGovern Medical School, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Kundu+MG%22">Kundu MG</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+J%22">Yoon J</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Kennedy+E%22">Kennedy E</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pai+M%22">Pai M</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Bain+E%22">Bain E</searchLink>; AbbVie, North Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Lassman+AB%22">Lassman AB</searchLink>; Division of Neuro-Oncology, Department of Neurology and the Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Moazami+G%22">Moazami G</searchLink>; Department of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220267442%22">Ophthalmic research</searchLink> [Ophthalmic Res] 2023; Vol. 66 (1), pp. 1030-1043. <i>Date of Electronic Publication: </i>2023 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0267442 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0259 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200303747%22">00303747 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmic Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37257422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000531142
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1030
    Titles:
      – TitleFull: A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vize CJ
      – PersonEntity:
          Name:
            NameFull: Kim SK
      – PersonEntity:
          Name:
            NameFull: Matthews T
      – PersonEntity:
          Name:
            NameFull: Macsai M
      – PersonEntity:
          Name:
            NameFull: Merrell R
      – PersonEntity:
          Name:
            NameFull: Hsu S
      – PersonEntity:
          Name:
            NameFull: Kundu MG
      – PersonEntity:
          Name:
            NameFull: Yoon J
      – PersonEntity:
          Name:
            NameFull: Kennedy E
      – PersonEntity:
          Name:
            NameFull: Pai M
      – PersonEntity:
          Name:
            NameFull: Bain E
      – PersonEntity:
          Name:
            NameFull: Lassman AB
      – PersonEntity:
          Name:
            NameFull: Moazami G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1423-0259
          Numbering:
            – Type: volume
              Value: 66
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Ophthalmic research
              Type: main
ResultId 1